Strides Arcolab has reported results for first quarter ended March 31, 2013.

The company has reported a net profit of Rs 31.57 crore for the quarter ended March 31, 2013 as compared to a net loss of Rs 28.16 crore for the same quarter in the previous year. Total income from operation of the company has increased by 33.49% at Rs 195.05 crore for quarter under review as compared to Rs 146.12 crore for the quarter ended March 31, 2012.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

1448.00 22.80 (1.60%)
04-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1910.50
Dr. Reddys Lab 6635.50
Cipla 1622.85
Lupin 2197.60
Zydus Lifesciences 1057.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.